Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.

导出 LinkOut

翻译打印收藏纠错

作者： Claus,Bachert ^[1] ; Philippe,Gevaert ^[2] ; Brian,Lipworth ^[3] ; Syed Shahzad,Mustafa ^[4] ; Andrew P,Lane ^[5] ; Joaquim,Mullol ^[6] ; Paul,Rowe ^[7] ; Yamo,Deniz ^[8] ; Siddhesh,Kamat ^[8] ; Asif H,Khan ^[7] ; Juby,Jacob-Nara ^[7] ; Shahid,Siddiqui ^[8] ; Marcella,Ruddy ^[8] ; Elizabeth,Laws ^[7] ; Jérôme,Msihid ^[9] ; Sivan,Harel ^[8] ; Alexandre,Jagerschmidt ^[10] ; Nikhil,Amin ^[8] ; Leda,Mannent ^[9] ; Raj,Rout ^[11]

作者单位： University Hospital of Münster, Münster, Germany.;Sun Yat-sen University, The First Affiliated Hospital, Guangzhou, China. ^[1] Ghent University, Ghent, Belgium. ^[2] University of Dundee, Dundee, UK. ^[3] Rochester Regional Health, Rochester, New York, USA. ^[4] Johns Hopkins School of Medicine, Baltimore, Maryland, USA. ^[5] Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, CIBERES, Barcelona, Catalonia, Spain. ^[6] Sanofi, Bridgewater, New Jersey, USA. ^[7] Regeneron Pharmaceuticals, Tarrytown, New York, USA. ^[8] Sanofi, Gentilly, France. ^[9] Sanofi, Chilly-Mazarin, France. ^[10] Sanofi, Reading, UK. ^[11]